Position in COYA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$98,500
New position
Shares Held
25,000
first reported quarter
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC Bancorp USA Inc. holds $155,785,536 across 65 Biotechnology names. COYA ranks #53 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
169,031 | $55,927,285 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
63,952 | $28,557,125 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,263 | $19,519,203 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
207,796 | $11,738,395 | |
| 5 | INCY |
Incyte Corp
|
56,458 | $5,313,826 | |
| 6 | MRNA |
Moderna, Inc.
|
98,515 | $5,004,561 | |
| 7 | TECH |
BIO-TECHNE Corp
|
66,339 | $3,466,875 | |
| 8 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
1,800,000 | $2,808,000 |
All Filings in COYA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $98,500 | 25,000 | Principal | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||